ARCHIVES

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

This article is from The Cancer Letter archive.

Vol. 40 No. 30 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCCP Board Okays New, Recompeting Contracts Worth $4.6 Million In ‘81

October 17, 1980

Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says

August 8, 1980

NCI Beings Accelerated Review Of R01s That just Miss Payline

March 29, 1996

In Brief: AMA Opposes Bill To Permit Heroin Use For Pain Control, Says Morphine Is Equally As Effective

March 23, 1984

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

August 27, 2004